Filing Flows › Bio Green Med Solution (BGMS) › Q4 2025
Bio Green Med Solution (BGMS) Q4 2025 earnings results (fourth quarter 2025)
10-K filed Mar 30, 2026
Bio Green Med Solution (BGMS) reported revenue of $666K for the fourth quarter 2025 (Q4 2025) and +722% from the quarter before. Operating margin was -162.5%, net loss $611K (91.7% of revenue).
Bio Green Med Solution, Q4 2025: revenue $666K, operating margin -162.5%, net loss $611K, operating cash flow −$33K. The chart follows the revenue to costs, profit and cash.
| Q4 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $666K | +722% | — |
| Operating profit | −$1.1M | — | — |
| Net earnings | −$611K | — | — |
| Operating cash flow | −$33K | — | — |
What changed
Revenue was $666K in Q4 2025, up 722% from the previous quarter.
Operating costs exceeded revenue by $1.1M, an operating margin of -162.5%. The quarter ended with a net loss of $611K, narrower than the previous quarter's $1.0M loss. Non-operating items added $476K, -79% of pre-tax earnings, so the bottom line overstates operating performance.
Operating cash flow was −$33K. Non-cash charges added back $4K of depreciation and $655K of share-based compensation. Working capital and other items used $81K.
Questions
What was Bio Green Med Solution's revenue in the fourth quarter 2025?
Bio Green Med Solution (BGMS) reported revenue of $666K for the fourth quarter 2025 (Q4 2025) and +722% from the quarter before.
Was Bio Green Med Solution profitable in the fourth quarter 2025?
Operating loss was $1.1M (-162.5% of revenue) and net loss $611K.